We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+62.68%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$470M
AUM Growth
+$215M
Cap. Flow
+$84.2M
Cap. Flow %
17.91%
Top 10 Hldgs %
50.14%
Holding
180
New
79
Increased
20
Reduced
20
Closed
47

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$19.9M
2
TMUS icon
T-Mobile US
TMUS
+$17.2M
3
ABBV icon
AbbVie
ABBV
+$12.5M
4
LITE icon
Lumentum
LITE
+$11.5M
5
QCOM icon
Qualcomm
QCOM
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Healthcare 17.02%
3 Consumer Staples 13.31%
4 Industrials 11.19%
5 Consumer Discretionary 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
176
CALL
DELISTED
Twitter, Inc.
TWTR
-60,000
Closed -$1.47M
ATHX
177
DELISTED
Athersys, Inc. Common Stock
ATHX
-400
Closed -$30K
PLAN
178
DELISTED
Anaplan, Inc.
PLAN
-110,500
Closed -$3.34M
APHA
179
DELISTED
Aphria Inc. Common Shares
APHA
-30,000
Closed -$92K
VRML
180
DELISTED
Vermillion, Inc.
VRML
-117,568
Closed -$98K

Similar funds

Ardsley Advisory Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Ardsley Advisory Partners held 180 positions worth $470M, up 84% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Ardsley Advisory Partners deployed $84.2M of net new capital in Q2 2020, opening 79 new positions and adding to 20 existing holdings. Its largest new stake was T-Mobile US: 179,510 shares worth $18.7M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $8.88M trimmed.

  • Ardsley Advisory Partners's largest Q2 2020 buy was T-Mobile US: 179,510 shares worth $18.7M.
  • Ardsley Advisory Partners added most to Microsoft in Q2 2020, an estimated $19.9M increase.
  • Ardsley Advisory Partners's biggest Q2 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $8.88M.
  • Ardsley Advisory Partners fully exited ZENDESK INC in Q2 2020, selling an estimated $6.08M.
  • Ardsley Advisory Partners's ten largest holdings make up 50% of its $470M portfolio in Q2 2020.
  • Ardsley Advisory Partners opened 79 new positions and closed 47 in Q2 2020.
  • Ardsley Advisory Partners's portfolio value rose 84% quarter-over-quarter to $470M.

Based on Ardsley Advisory Partners's 13F filing for Q2 2020, filed 14 Aug 2020.